Universal-Beteiligungs- und Servicegesellschaft’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
EAM
Universal-Beteiligungs- und Servicegesellschaft's MDGL Position: Q2 2026 in Review
Universal-Beteiligungs- und Servicegesellschaft reduced its Madrigal Pharmaceuticals (MDGL) stake by 23% in Q2 2026, selling an estimated $2.15M and leaving 14,263 shares worth $7.66M. The position accounts for 0.01% of the portfolio, ranked #756.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in MDGL in Q1 2025 and has held it in 6 quarters since. The position peaked at $11.1M in Q4 2025. 229 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.
- Universal-Beteiligungs- und Servicegesellschaft held 14,263 shares of Madrigal Pharmaceuticals worth $7.66M as of Q2 2026.
- Universal-Beteiligungs- und Servicegesellschaft sold 4,189 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $2.15M.
- Madrigal Pharmaceuticals made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #756 holding.
- Universal-Beteiligungs- und Servicegesellschaft first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- Universal-Beteiligungs- und Servicegesellschaft's Madrigal Pharmaceuticals position peaked at $11.1M in Q4 2025.
- 229 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.
Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.